About

MED‑Project is a subsidiary established by the Pharmaceutical Product Stewardship Work Group (PPSWG) to develop, implement, and operate safe, effective, compliant programs for the disposal of household pharmaceutical products in adherence with state and local legislation. MED‑Project is a non-profit, 501(c)(3) tax-exempt organization.

Visit the PPSWG website to learn more about the work of PPSWG or if you are a producer interested in joining the association.

Working as an accountable organization, on behalf of producers, MED‑Project effectively operates take-back programs for unwanted medications and sharps from households.

MED‑Project’s programs are designed and operated to meet all applicable program requirements and federal, state, and local laws and regulations, providing comprehensive compliance systems and risk mitigation across all mandated jurisdictions.

MED‑Project executes on its purpose to provide safe, secure, cost-effective, take-back programs for unwanted pharmaceutical products from households, delivering compliant programs for producers.

Collection & Disposal

Outreach & Education

Program Administration

Board of Directors

MED‑Project’s governing bodies monitor the performance and quality compliance of all pharmaceutical product stewardship programs.

The Board of Directors is appointed by the Pharmaceutical Product Stewardship Work Group Board of Directors to represent the collective’s interests and provide governance and oversight to the compliance, financial strategies, operations, and regulatory affairs executed by MED‑Project.

Stacy Burch – Chair

Vice President, North America Marketing

Embecta

Rachel Young – Vice Chair

Associate Counsel

Viatris

Ray Sharples – Past Chair

Senior Manager, Environmental Product Compliance, Governance, and Strategy

Johnson & Johnson

Stephanie Barlow

Director, Returns Processing and Rebate Support

Teva

Lorraine Cancro

Global Director, Environmental Compliance & Remediation

GlaxoSmithKline

Colin Chiles

Sr. Director, State Government Relations

Viatris

Erin Gasway

Senior Director - US Public Policy

Eli Lilly and Company

Rob Somers

Global Director EHS

Perrigo

Peter Wilson

Manager, Environment, Corporate

Sanofi US

Leadership Team

MED‑Project leadership manages the compliance, financial implementation, and operations of the pharmaceutical product stewardship plans.

Michael Van Winkle

MS, CIH

Executive Director

Kim Peterson

CPA

Lead Director of Finance and Administration

Dr. Victoria Travis

PharmD, MS, MBA

National Program Director

Jim Wilson

JD, MS, MSM, P.E.

Lead Director of Compliance and Risk Management

Adam Burkhardt

MS, PMP, PMI-ACP

Senior Director, Data Services & Project Management Center of Excellence

Delivering on Priorities

• Detailed implementation and compliance plans to meet all the requirements of each unique jurisdiction
• Brand-safe outreach and education materials
• Cost-effective compliance and implementation